COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff. Learn more about guidelines for the resumption of live
(in-person) courses and conferences
effective July 1, 2021 and available COVID-19 online education and resources.
Oncopeptides - Exhibitor

Company Website

Contact information

Matt Krusemark
matt.krusemark@oncopeptides.com
651-587-0697

Virtual Exhibit Hall Home

Oncopeptides was established solely to develop therapies for difficult-to-treat haematological diseases, and we are committed to bringing patients the treatments they need and the hope they deserve.